Although this was a longitudinal analysis that was strongly suggestive that quitting smoking plays a role in improved recovery outcomes from other substance use disorders, further research will be ...

The Leukemia & Lymphoma Society is becoming Blood Cancer United on August 28, in advance of Blood Cancer Awareness Month in September.

On August 8, the Food and Drug Administration (FDA) granted accelerated approval of Hernexeos (zongertinib), a new targeted therapy for previously treated people with inoperable or metastatic ...

Good nutrition can help reduce fatigue. There isn’t one food that reduces fatigue but focusing on a diet rich in nutrient-dense foods will provide protein, energy, vitamins and minerals to support ...

It’s a relatively common type of cancer. That’s the one thing Janet Kukreja, MD, director of urologic oncology at the CU Cancer Center and UCHealth University of Colorado Hospital, wants people to ...

University of Colorado researcher studied the role of Focal Adhesion Kinase in promoting the growth and spread of cancer cells.

SEATTLE — July 23, 2025 — A landmark study has revealed that autoantibodies — immune proteins traditionally associated with autoimmune disease — may profoundly influence how cancer patients respond to ...

Results showed that being a firefighter increased the mortality risk for most cancers, but the risk was strongest for skin and kidney cancers. For skin cancer, the mortality rate for firefighters was ...

Glucagon-like peptide-1 receptor agonist drugs (GLP-1s) such as Wegovy and Zepbound, have become game-changers in the world of weight-loss drugs. By reducing appetite and slowing down the rate at ...

Researchers say the increase in colorectal cancer screening among younger adults is linked to rise in earlier-stage diagnosis.

A University of Colorado researcher discusses a study that explored a new treatment strategy for children with neuroblastoma.

July 31, 2025• By Liz Highleyman Share Comments Print Advertisement Two antibody-drug conjugates, Enhertu (trastuzumab deruxtecan) and Trodelvy (sacituzumab govitecan), delayed disease progression for ...